Molecular targeted therapy for anticancer treatment
HY Min, HY Lee - Experimental & molecular medicine, 2022 - nature.com
Since the initial clinical approval in the late 1990s and remarkable anticancer effects for
certain types of cancer, molecular targeted therapy utilizing small molecule agents or …
certain types of cancer, molecular targeted therapy utilizing small molecule agents or …
Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer
Normal cells explore multiple states to survive stresses encountered during development
and self-renewal as well as environmental stresses such as starvation, DNA damage, toxins …
and self-renewal as well as environmental stresses such as starvation, DNA damage, toxins …
Three-Dimensional in Vitro Cell Culture Models in Drug Discovery and Drug Repositioning
SA Langhans - Frontiers in pharmacology, 2018 - frontiersin.org
Drug development is a lengthy and costly process that proceeds through several stages
from target identification to lead discovery and optimization, preclinical validation and …
from target identification to lead discovery and optimization, preclinical validation and …
Risk and outcome of breakthrough COVID-19 infections in vaccinated patients with cancer: real-world evidence from the national COVID cohort collaborative
Q Song, B Bates, YR Shao, FC Hsu, F Liu… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE To provide real-world evidence on risks and outcomes of breakthrough COVID-
19 infections in vaccinated patients with cancer using the largest national cohort of COVID …
19 infections in vaccinated patients with cancer using the largest national cohort of COVID …
COVID-19 vaccines for patients with cancer: benefits likely outweigh risks
Less than a year since the start of the COVID-19 pandemic, ten vaccines against SARS-CoV-
2 have been approved for at least limited use, with over sixty others in clinical trials. This …
2 have been approved for at least limited use, with over sixty others in clinical trials. This …
Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review
K Pandey, HJ An, SK Kim, SA Lee… - … journal of cancer, 2019 - Wiley Online Library
Deregulation of the cyclin D‐CDK4/6‐INK4‐RB pathway leading to uncontrolled cell
proliferation, is frequently observed in breast cancer. Currently, three selective CDK4/6 …
proliferation, is frequently observed in breast cancer. Currently, three selective CDK4/6 …
New advances in the research of resistance to neoadjuvant chemotherapy in breast cancer
J An, C Peng, H Tang, X Liu, F Peng - International journal of molecular …, 2021 - mdpi.com
Breast cancer has an extremely high incidence in women, and its morbidity and mortality
rank first among female tumors. With the increasing development of medicine today, the …
rank first among female tumors. With the increasing development of medicine today, the …
An update on the status of vaccine development for SARS-CoV-2 including variants. Practical considerations for COVID-19 special populations
B Kantarcioglu, O Iqbal, J Lewis… - Clinical and Applied …, 2022 - journals.sagepub.com
The progress in the development of various vaccine platforms against SARS-CoV-2 have
been rather remarkable owing to advancement in molecular and biologic sciences. Most of …
been rather remarkable owing to advancement in molecular and biologic sciences. Most of …
Pharmacologic targeting of Nedd8-activating enzyme reinvigorates T-cell responses in lymphoid neoplasia
X Wang, C Chen, D Vuong, S Rodriguez-Rodriguez… - Leukemia, 2023 - nature.com
Neddylation is a sequential enzyme-based process which regulates the function of E3 Cullin-
RING ligase (CRL) and thus degradation of substrate proteins. Here we show that CD8+ T …
RING ligase (CRL) and thus degradation of substrate proteins. Here we show that CD8+ T …
Role of epidermal growth factor receptor inhibitor-induced interferon pathway signaling in the head and neck squamous cell carcinoma therapeutic response
Background Epidermal growth factor receptor (EGFR) is frequently amplified or
overexpressed in head and neck squamous cell carcinoma (HNSCC) and is a clinically …
overexpressed in head and neck squamous cell carcinoma (HNSCC) and is a clinically …